Myocardial glucose utilization and optimization of 18F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction

Journal of Nuclear Medicine

Volumn 42, Issue 12, 2001, Pages 1730-1736

  Vitale, G D ^a   Dekemp, R A ^a   Ruddy, T D ^a   Williams, K ^a   Beanlands, R S B ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Coronary disease; Diabetes mellitus; FDG; Myocardial dysfunction; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NICOTINIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE METABOLISM; HUMAN; IMAGE QUALITY; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; MYOCARDIUM; NIACIN; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035659343     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with CAD and LV dysfunction
2. Reversibility of cardiac wall motion abnormalities predicted by positron tomography
3. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
4. 18F-labelled fluorodeoxyglucose and N-13 ammonia
5. FDG PET imaging alters clinical decision making in patients with impaired ventricular function
6. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by PET
7. Investigation of factors influencing FDG myocardial image quality
8. Euglycemic clamp and oral glucose load in stimulating myocardial glucose utilization during PET
9. Effect of nicotinic acid on exogenous myocardial glucose utilization
10. Enhancement of myocardial FDG uptake by a nicotinic acid derivative
11. Myocardial glucose metabolism in NIDDM patients evaluated by FDG-PET
12. Clinical PET protocols
13. Glucose clamp technique: A method for quantifying insulin secretion and resistance
14. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
15. Graphical evaluation of blood-brain transfer constants from multiple-time uptake data generalizations
16. Regional perfusion, glucose metabolism and wall motion in patients with chronic electrocardiographic Q-wave infarctions: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography
17. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET
18. The effect of insulin and FFA on myocardial glucose uptake
19. Attenuated response of myocardial glucose utilization to insulin stimulation in hibernating myocardium
20. Contraction-induced translocation of the glucose transporter Glut4 in isolated ventricular cardiomyocytes
21. Altered glucose transporter mRNA levels in cardiac ischemia
22. Chronic myocardial hibernation in humans: From bedside to bench
23. Ischemia induced translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes
24. Myocardial metabolism in ischemic heart disease: Basic principles and application to imaging by positron emission tomography
25. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans
26. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism
27. Fundamental limitations of FDG for assessing myocardial glucose uptake
28. 18F]fluorodeoxyglucose
29. 18F-FDG-SPECT studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping
30. Myocardial F-18 fluorodeoxyglucose imaging by SPECT
31. Comparison of myocardial uptake of F-18 fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium
32. Direct comparison of fluorine18-FDG SPECT, fluorine- 18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability
33. ECAT ART: A continuously rotating PET camera-performance characteristics, initial clinical studies, and installation considerations in a nuclear medicine department